Hepion Pharmaceuticals, Inc.

New Filing
CIK: 0001583771·Pharmaceuticals·DELAWARE·Filed: Oct 3, 2023
Total Offering

$5,000,004

Amount Sold

$5,000,004

Investors

1

First Sale

Sep 28, 2023

Offering Details

Type
Equity, Option to Acquire
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Robert Foster
Related Person
John Cavan
Related Person
Anand Reddi
Related Person
Gary S. Jacob
Related Person
John P. Brancaccio
Related Person
Timothy Block
Related Person
Kaouthar Lbiati
Related Person
Petrus Wijngaard
Related Person

Company

Hepion Pharmaceuticals, Inc.

399 THORNALL STREET

EDISON, NJ, 208837

732-902-4000

SEC Filing

0001104659-23-106467

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free